myxofibrosarcoma: a retrospective analysis of 158 patients
DESCRIPTION
Myxofibrosarcoma: a retrospective analysis of 158 patients. Sanfilippo R , Grosso F, Pennacchioli E, Barisella M, Fiore M, Morosi C, Collini P, Casali PG, Gronchi A. Roberta Sanfilippo [email protected]. Myxofibrosarcoma. INT, Milano May 1994 - February 2009. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/1.jpg)
Myxofibrosarcoma:
a retrospective analysis of 158 patients
Sanfilippo R, Grosso F, Pennacchioli E, Barisella M, Fiore M, Morosi C, Collini P, Casali PG, Gronchi A
Roberta [email protected]
![Page 2: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/2.jpg)
Myxofibrosarcoma
![Page 3: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/3.jpg)
INT, Milano May 1994 - February 2009
![Page 4: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/4.jpg)
Patients’ characteristics Median age (I.Q. range) 64 yrs (54-72)
Sex Male 56% Female 44%
Median size(I.Q. range) 5 (3-9) cm
Deep site 56%
Grade (FNCLCC)grade I 22%
grade II 42%
grade III 36%
![Page 5: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/5.jpg)
Patients’ characteristics
Primary tumor
Recurrent tumor
Chemotherapy
Done 14%Not Done 86%
RadiotherapyDone 51% Not Done 49%
![Page 6: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/6.jpg)
Tumor sites
Head&neck 1%
Trunk 14%
Upper extremities 24%
Lower extremities 61%
![Page 7: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/7.jpg)
Surgery
Surgical Procedure
Conservative 157/158
Amputation 1/158 (1/132)
Surgical margins
Negative 82%
Positive 18%
extremities
![Page 8: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/8.jpg)
OS
0 12 24 36 48 60
0.0
0.2
0.4
0.6
0.8
1.0
Time (months)
Su
rviv
al p
rob
abil
ity
OS@5yrs=77%
Median follow-up (from surgery): 53 months
![Page 9: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/9.jpg)
Presentation: recurrent 1.82 (0.79, 4.17) 0.159
vs primary
Depht: deep vs superficial 0.76 (0.30, 1.91) 0.558
Size: 9 vs 3 cm 3.46 (1.13,10.62) 0.005
Grade : III vs II&I 4.76 (2.15, 10.54) <0.0001
Margins: positive vs negative 2.51 (1.08,5.82) 0.032
RT: done vs not done 1.31 (0.58,2.97) 0.522
CT: done vs not done 0.65 (0.22,1.88) 0.422
Multivariate analysis for OS
HR P
![Page 10: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/10.jpg)
LR and M
0 12 24 36 48 60
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
Time (months)
Pro
bab
ilit
yCrude cumulative incidence
Distant metastasis
Local relapse
Median follow-up (from surgery): 53 months
LR@5yrs=18%DM@5yrs=15%
![Page 11: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/11.jpg)
Univariate analysis for LR HR P
Presentation: recurrent 1.03 (0.43, 2.43) 0.95
vs primary
Depht: deep vs superficial 1.50 (0.69,3.28) 0.3081
Size: 9 vs 3 cm 1.23(0.51-2.96) 0.115
Site: extremity vs other 1.56 (0.47, 5.18) 0.4691
Grade : II vs I 0.67 (0.29, 1.55)0.3472
III vs II 0.46 (0.16, 1.35)
Margins: positive vs negative 5.40 (2.46, 11.86) <.0001
RT: done vs not done 1.36 (0.63, 2.91) 0.4321
CT: done vs not done 1.87 (0.64, 5.49) 0.2555
![Page 12: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/12.jpg)
Presentation: recurrent 0.61 (0.23, 1.60) 0.314
vs primary
Depht: deep vs superficial 1.08 (0.41, 2.82) 0.875
Size: 9 vs 3 cm 0.87 (0.30,2.56) 0.859
Margins: positive vs negative 5.63 (2.06,15.38) <0.001**
Grade : III vs II&I 0.80 (0.29, 2.21) 0.662
RT: done vs not done 1.07 (0.47,2.44) 0.863
Multivariate analysis for LR
HR P
![Page 13: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/13.jpg)
Presentation: recurrent 1.74 (0.66, 4.57) 0.264 vs primary
Depht: deep vs superficial 1.55 (0.47, 5.09) 0.475
Size: 9 vs 3 cm 1.18(0.32-4.32) 0.728
Grade : III vs I/II 5.35 (1.93, 14.84) 0.001
Margins: positive vs negative 2.86 (0.90,9.06) 0.074
CT: done vs not done 0.84 (0.27,2.62) 0.760
Multivariate analysis for M
HR P
**
![Page 14: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/14.jpg)
OS Myxofibrosarcoma G3
0 12 24 36 48 60
0.0
0.2
0.4
0.
60
.81
.0
Su
rviv
al p
rob
abil
ity
%
Time (months)
OS@5yrs=64.5%
![Page 15: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/15.jpg)
0 12 24 36 48 60
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
0.26
0.28
0.30
Pro
bab
ilit
y
LR and M in G3 Myxofibrosarcoma
Distant metastasis
Local relapse
Time (months)
LR@5yrs=11%DM@5yrs=27%
![Page 16: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/16.jpg)
![Page 17: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/17.jpg)
Patterns of metastasis
20%
![Page 18: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/18.jpg)
“Infiltrative margins”
![Page 19: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/19.jpg)
Positive margins (I.Q. range) 9.5 (5-16.5) cm
Negative margins (I.Q. range)5 (3-7) cm
Median size
Margins and size
![Page 20: Myxofibrosarcoma: a retrospective analysis of 158 patients](https://reader030.vdocuments.net/reader030/viewer/2022033016/568139db550346895da18f11/html5/thumbnails/20.jpg)
Conclusions Myxofibrosarcomas have a good prognosis, and
even high-grade ones have a comparatively low risk of metastases
By contrast, the local relapse rate is definetely higher, likely due to the typically higher infiltrative pattern of growth
However, the local recurrence rate does not seem to influence the outcome
Though in the presence of an obvious selection bias in this series, the role of radiation therapy is left to be defined